Abstract
Studies on cancer immunology are now being conducted extensively in Japan. Since the beginning of the 1970s when living BCG and Corynebacterium parvum were widely applied to human cancer immunotherapy in the United States and European countries, various kinds of cancer immunotherapeutics have been employed for the treatment of cancer patients. However, clinical applications of Corynebacterium parvum and BCG, which were widely used as an antituberculosis vaccine in Japan, were not suitably employed in human cancer treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Azuma, I., T. Taniyama, F. Hirao and Y. Yamamura, Y., Gann, 65: 493 (1974).
Azuma, I. and Y. Yamamura, 1979, GANN Monogr. Cancer Res., 24: 121 (1979).
Chihara, G., Y.Y. Maeda, J. Hamuro, T. Sadaki and F. Fukuoka, Nature, 222: 687 (1969).
Ellouz, F., A. Adam, R. Ciorbaru and E. Lederer, Biophys. Res. Commun., 59: 1317 (1974).
Furue, H., I. Itoh, T. Kimura, T. Kondo, T. Hattori, N. Ogawa and T. Taguchi, GAN TO KAGAKURYOHO, 8: 944 (in Japanese) (1981).
Ikeda, S., in 13th International Cancer Congress (Abstract) (1982).
Kotani, S., Y. Watanabe, F. Kinoshita, T. Shimono, I. Morisaki, T. Shiba, S. Kusumoto, Y. Tarumi and K. Ikenaka, K., Biken J., 18: 105 (1975).
Ogura, T., M. Namba, Y. Yamamura and I. Azuma, in: “Immunology and Immunotherapy of Cancer,” W.D. Terry and Y. Yamamura eds., Elsevier North-Holland Publishers, New York (1979).
Okada, M., N. Yoshimura, T. Kaieda, Y. Yamamura and T. Kishimoto, Proc. Nat. Acad. Sci. U.S.A., 78: 7717 (1981).
Okamoto, H., S. Shoin, S. Koshimura and R. Shimizu, Jap. J. Microbiol., 11: 323 (1967).
Saiki, I., Y. Tanio, M. Yamawaki, M. Uemiya, S. Kobayashi, T. Fukuda, H. Yukimasa, Y. Yamamura and I. Azuma, Infect. Immun., 31: 114 (1981).
Tokai Cooperative Study Group of Adjuvant Immuno-chemotherapy of the Stomach Cancer, Cancer Chemother., 3: 715 (1976).
Uchida, A. and T. Hoshino, Cancer, 45: 476 (1980).
Umezawa, H., T. Aoyagi, H. Suda, M. Hamada and T. Takeuchi, J. Antibiot., 29: 97 (1976).
Yamamura, Y., I. Azuma, K. Sugimura, M. Yamawaki, M. Uemiya, M. Kusumoto, M., S. Okada and T. Shiba, Gann, 67: 867 (1976).
Yamamura, Y., K. Yasumoto, T. Ogura and I. Azuma, in: “Augmenting Agents in Cancer Immunology,” E.M. Hersh, Raven Press, New York (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Yamamura, Y., Azuma, I. (1984). Cancer Immunotherapy in Japan. In: Fudenberg, H.H., Whitten, H.D., Ambrogi, F. (eds) Immunomodulation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9358-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9358-4_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9360-7
Online ISBN: 978-1-4615-9358-4
eBook Packages: Springer Book Archive